AI assistant
MEMPHASYS LIMITED. — Share Issue/Capital Change 2009
Jul 9, 2009
65314_rns_2009-07-09_d35f030c-9150-41ca-9ea3-417cf5cddce6.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
FOR IMMEDIATE RELEASE
==> picture [173 x 57] intentionally omitted <==
NuSep Advises the Market of the 1 for 20 Share Consolidation
– SYDNEY, AUSTRALIA – 10[th ] July 2009 NuSep (ASX: NSP) wishes to advise the market that its share capital was consolidated in March on a 1 for 20 basis.
In March 2009 the issued capital of the company was reduced from 45,965,467 shares to 2,298,907 shares. NuSep’s shares last traded on 12 March 2009 at 5¢ which valued the Company at $2.29m. On a post consolidated capital basis this market valuation translates to a share price of approximately $1 per share.
| Pre 1:20 Consolidation | Post 1:20 Consolidation | |
|---|---|---|
| NSP Shares on Issue | 45,965,467 shares | 2,298,907 shares |
| Market Price of NSP on 12 March 2009 |
5¢ per share | $1 per share |
| Market Capitalisation on 12 March 2009 |
$2,298,273 | $2,298,273 |
Shareholders should be aware of this 1 for 20 share consolidation before they buy or sell their shares in NuSep.
About NuSep
NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global bioseparations market. The company has offices in both Sydney, Australia and Atlanta, USA.
With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification.
NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.
NuSep Products:
==> picture [13 x 10] intentionally omitted <==
Gels – NuSep manufactures and sells precast gels including the innovative iGels, with a 2 year shelf life.
Postal Address Contact Details Email [email protected] P.O. Box 823 Telephone +61 2 8977 9000 Web www.nusep.com Lane Cove NSW 1595 Facsimile +61 2 8977 9099 ABN 33 120 047 556
NuSep Ltd 324 Burns Bay Rd Lane Cove NSW 2066
– 2 –
==> picture [13 x 10] intentionally omitted <==
==> picture [13 x 10] intentionally omitted <==
-
Separation Instruments – NuSep has developed two unique biological separation instruments. The first instrument released in 2008 can separate biological samples into 8 fractions for use in the proteomic market. The second instrument separates sperm for fertility treatments such as IVF and is presently undergoing clinical trials.
-
Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin.
For more information about NuSep please visit the company’s website www.NuSep.com
Contact: Prakash Patel Chief Financial Officer & Company Secretary +61 2 8977 9000 [email protected]